Interleukin-2 bolus therapy induces immediate and selective disappearance from peripheral blood of all lymphocyte subpopulations displaying natural killer activity: Role of cell adhesion to endothelium

This publication has 18 references indexed in Scilit:

• Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium.
  The Journal of Experimental Medicine, 1991
• Adhesion receptors of the immune system
  Nature, 1990
• Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes
  Cell, 1989
• Cytokines as communication signals between leukocytes and endothelial cells
  Immunology Today, 1989
• Endothelial Leukocyte Adhesion Molecule 1: an Inducible Receptor for Neutrophils Related to Complement Regulatory Proteins and Lectins
  Science, 1989
• Phenotypic and functional characterization of lymphocytes that bind human microvascular endothelial cells in vitro. Evidence for preferential binding of natural killer cells.
  Journal of Clinical Investigation, 1987
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Specific Cell-Adhesion Mechanisms Determining Migration Pathways of Recirculating Lymphocytes
  Annual Review of Immunology, 1987
• Integrins: A family of cell surface receptors
  Cell, 1987
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985